UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by ING Groep NV

ING Groep NV grew its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 117,274 shares of the healthcare conglomerate's stock after buying an additional 7,308 shares during the quarter. ING Groep NV's holdings in UnitedHealth Group were worth $59,324,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in UNH. M&T Bank Corp raised its stake in UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock valued at $128,975,000 after purchasing an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after buying an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. increased its holdings in UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock valued at $26,060,000 after acquiring an additional 41,308 shares during the last quarter. Parsifal Capital Management LP bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $21,165,000. Finally, Signal Advisors Wealth LLC increased its holdings in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock worth $4,611,000 after purchasing an additional 1,051 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on UNH. Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. KeyCorp reaffirmed an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. Finally, Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Buy" and an average price target of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Down 7.3 %

Shares of UNH stock traded down $36.84 during trading hours on Friday, reaching $465.58. 19,536,522 shares of the company's stock were exchanged, compared to its average volume of 4,729,468. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $428.46 billion, a price-to-earnings ratio of 30.04, a P/E/G ratio of 1.40 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock's 50 day moving average is $520.37 and its 200-day moving average is $561.26.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company earned $5.83 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.